
  
    
      
        Background_NNP
        Although_IN electrocardiograms_NNS (_( ECGs_NNP )_) have_VBP been_VBN obtained_VBN in_IN
        conscious_JJ mice_NNS ,_, currently_RB reported_VBD techniques_NNS require_VBP
        restraint_NN [_NN 1_CD ]_NN or_CC anesthesia_NN and_CC surgical_JJ implantation_NN of_IN
        telemetry_NN devices_NNS [_NN 2_CD ,_, 3_CD ,_, 4_CD ]_NN ._. Anesthesia_NNP ,_, however_RB ,_, may_MD
        depress_VB cardiovascular_JJ function_NN ,_, and_CC adequate_JJ recovery_NN
        after_IN transmitter_NN implantation_NN in_IN mice_NNS is_VBZ nearly_RB 3_CD weeks_NNS [_NN
        3_CD ,_, 5_CD ]_NN ._. Accordingly_RB ,_, we_PRP developed_VBD a_DT non-invasive_JJ technique_NN
        for_IN obtaining_VBG ECGs_NNP in_IN conscious_JJ mice_NNS by_IN placing_VBG the_DT animal_NN
        on_IN a_DT platform_NN embedded_VBN with_IN paw-sized_JJ ECG_NNP electrodes_NNS
        connected_VBN to_TO an_DT amplifier_NN ._. This_DT method_NN is_VBZ much_RB less_RBR
        traumatic_JJ ,_, requires_VBZ no_DT anesthesia_NN or_CC surgery_NN ,_, and_CC promotes_VBZ
        rapid_JJ screening_NN of_IN large_JJ quantities_NNS of_IN mice_NNS ._. ECG_NNP data_NNS we_PRP
        obtained_VBD non-invasively_JJ in_IN conscious_JJ mice_NNS are_VBP comparable_JJ to_TO
        those_DT recently_RB published_VBN using_VBG surgically_RB implanted_VBN
        telemetry_NN devices_NNS [_NN 2_CD ,_, 4_CD ]_NN ._. To_TO test_VB the_DT efficacy_NN of_IN our_PRP$
        system_NN ,_, we_PRP evaluated_VBD ECGs_NNP in_IN mice_NNS of_IN either_DT sex_NN ,_, of_IN several_JJ
        strains_NNS ,_, and_CC of_IN different_JJ ages_NNS ._. Moreover_RB ,_, we_PRP tested_VBD whether_IN
        our_PRP$ system_NN could_MD detect_VB ECG_NNP alterations_NNS in_IN response_NN to_TO
        pharmacological_JJ challenge_NN by_IN isoproterenol_NN ._. The_DT baseline_NN
        heart_NN rate_NN data_NNS and_CC responses_NNS to_TO the_DT β-adrenergic_JJ agonist_NN
        isoproterenol_NN we_PRP recorded_VBD non-invasively_JJ in_IN mice_NNS are_VBP
        comparable_JJ to_TO data_NNS published_VBD using_VBG invasive_JJ methods_NNS [_NN 6_CD ]_NN ._. We_PRP
        developed_VBD an_DT ECG_NNP signal_NN processing_NN ,_, analyzing_VBG ,_, and_CC database_NN
        Web_NNP portal_NN ,_, which_WDT we_PRP named_VBD e-_NN MOUSE_NNP ™_NN ,_, accessible_JJ to_TO the_DT
        biotechnology_NN community_NN ._. The_DT advantages_NNS of_IN the_DT ECG_NNP
        recording_NN and_CC analyses_NNS paradigm_NN we_PRP developed_VBD are_VBP clear_JJ ,_,
        given_VBN the_DT high_JJ cost_NN of_IN breeding_VBG ,_, housing_NN ,_, and_CC transporting_VBG
        mice_NNS ,_, and_CC the_DT call_NN for_IN comprehensive_JJ yet_RB widely_RB available_JJ
        phenotyping_VBG tests_NNS [_NN 7_CD ]_NN ._.
      
      
        Results_NNS
        We_PRP recorded_VBD ECGs_NNP in_IN 10_CD males_NNS and_CC 10_CD females_NNS each_DT of_IN
        C_NNP 57_CD BL_NNP /_NN 6_CD ,_, 129_CD /_NN Sv_NNP ,_, and_CC FVB_NNP /_NN N_NNP mice_NNS ,_, three_CD inbred_JJ strains_NNS
        commonly_RB used_VBN to_TO model_VB human_JJ diseases_NNS ._. A_DT representative_JJ ECG_NNP
        recording_NN from_IN an_DT adult_NN male_JJ C_NNP 57_CD BL_NNP /_NN 6_CD mouse_NN is_VBZ shown_VBN in_IN Fig_NNP ._.
        1_LS ._. Since_IN the_DT mice_NNS are_VBP conscious_JJ ,_, baseline_NN artifact_NN and_CC
        noise_NN are_VBP apparent_JJ in_IN the_DT unfiltered_JJ signals_NNS ._. Yet_RB ,_, the_DT
        P-_NNP waves_NNS and_CC T-_NNP waves_NNS are_VBP discernible_JJ by_IN eye_NN and_CC
        interpretable_JJ by_IN the_DT software_NN algorithmic_JJ processing_NN of_IN the_DT
        signal_NN digitized_JJ at_IN 2500_CD samples_NNS per_IN second_NN ._. Analyses_NNS of_IN
        the_DT digitized_JJ signals_NNS via_IN e-_NN MOUSE_NNP ™_NN demonstrated_VBN
        significantly_RB faster_JJR heart_NN rates_NNS in_IN C_NNP 57_CD BL_NNP /_NN 6_CD female_JJ mice_NNS
        than_IN in_IN males_NNS (_( 741_CD ±_NN 2_CD bpm_NN vs_NNS ._. 692_CD ±_NN 5_CD bpm_NN ,_, 
        P_NN <_NN 0_CD ._. 05_CD ,_, n_NN =_SYM 10_CD )_) and_CC shorter_JJR QRS_NNP
        duration_NN (_( 7_CD ._. 5_LS ±_NN 0_CD ._. 2_CD ms_NNS vs_NNS ._. 8_CD ._. 1_CD ±_NN 0_CD ._. 2_CD ms_NNS ,_, 
        P_NN <_NN 0_CD ._. 05_CD )_) ._. Table_NNP 1_CD summarizes_NNS
        results_NNS in_IN 129_CD /_NN Sv_NNP mice_NNS (_( 10_CD males_NNS and_CC 10_CD females_NNS )_) ,_, again_RB
        demonstrating_VBG faster_JJR heart_NN rate_NN and_CC shorter_JJR QRS_NNP duration_NN
        and_CC QT_NNP interval_NN in_IN female_JJ mice_NNS than_IN in_IN age-matched_JJ males_NNS ._.
        Rate_NNP corrected_VBD QT_NNP (_( QTc_NNP )_) in_IN male_JJ 129_CD /_NN Sv_NNP mice_NNS was_VBD
        significantly_RB longer_RBR than_IN in_IN females_NNS (_( 66_CD ._. 7_CD ±_NN 1_CD ._. 9_CD ms_NNS vs_NNS ._.
        58_CD ._. 4_LS ±_NN 1_CD ._. 6_CD ms_NNS ,_, 
        P_NN <_NN 0_CD ._. 05_CD )_) ._. Gender_NNP differences_NNS in_IN
        heart_NN rate_NN were_VBD also_RB apparent_JJ in_IN the_DT FVB_NNP /_NN N_NNP strain_NN [_NN 736_CD ±_NN 5_CD
        bpm_NN in_IN males_NNS (_( n_NN =_SYM 10_CD )_) vs_NNS ._. 706_CD ±_NN 7_CD bpm_NN in_IN females_NNS (_( n_NN =_SYM 10_CD )_) ,_, 
        P_NN <_NN 0_CD ._. 05_CD ]_NN ._.
        Reducing_VBG the_DT spacing_VBG of_IN the_DT electrodes_NNS allowed_VBD us_PRP to_TO
        record_VB ECGs_NNP in_IN 6_CD -_: day_NN and_CC again_RB in_IN 12_CD -_: day_NN old_JJ nursling_VBG
        C_NNP 57_CD BL_NNP /_NN 6_CD mice_NNS (_( 8_CD males_NNS and_CC 5_CD females_NNS )_) and_CC return_VB them_PRP to_TO
        their_PRP$ mother_NN ._. The_DT ECG_NNP from_IN a_DT 6_CD -_: day-old_JJ C_NNP 57_CD BL_NNP /_NN 6_CD nursling_VBG
        female_NN is_VBZ shown_VBN in_IN Fig_NNP ._. 2_LS ._. Heart_NNP rate_NN variability_NN in_IN
        neonates_NNS was_VBD significantly_RB less_JJR than_IN in_IN adults_NNS (_( 2_CD ._. 5_LS ±_NN 0_CD ._. 4_CD
        bpm_NN vs_NNS ._. 21_CD ±_NN 2_CD bpm_NN ,_, 
        P_NN <_NN 0_CD ._. 05_CD )_) ._. Heart_NNP rate_NN in_IN nursling_VBG
        females_NNS was_VBD significantly_RB slower_JJR than_IN in_IN adult_NN females_NNS (_( 655_CD
        ±_NN 6_CD bpm_NN vs_NNS ._. 741_CD ±_NN 2_CD bpm_NN ,_, 
        P_NN <_NN 0_CD ._. 05_CD )_) ._. Interestingly_RB ,_, the_DT
        gender_NN differences_NNS in_IN heart_NN rate_NN we_PRP observed_VBD in_IN adult_NN mice_NNS
        were_VBD absent_JJ in_IN 6_CD -_: day_NN old_JJ and_CC 12_CD -_: day_NN old_JJ neonates_NNS ._. Upon_IN
        weaning_VBG (_( 21_CD days_NNS old_JJ )_) ,_, however_RB ,_, gender_NN differences_NNS in_IN heart_NN
        rate_NN became_VBD apparent_JJ [_NN 697_CD ±_NN 14_CD bpm_NN in_IN males_NNS (_( n_NN =_SYM 5_LS )_) vs_NNS ._. 750_CD
        ±_NN 8_CD bpm_NN in_IN females_NNS (_( n_NN =_SYM 3_LS )_) ,_, 
        P_NN <_NN 0_CD ._. 05_CD ]_NN ._.
        The_DT acute_JJ increase_NN in_IN heart_NN rate_NN within_IN the_DT first_JJ
        minutes_NNS following_VBG one_CD intraperitoneal_NN injection_NN of_IN the_DT
        β-adrenergic_JJ agonist_NN isoproterenol_NN (_( 2_CD ._. 5_LS μg_NN /_NN g_SYM )_) was_VBD
        significantly_RB less_JJR in_IN female_JJ compared_VBN to_TO male_JJ C_NNP 57_CD BL_NNP /_NN 6_CD adult_NN
        mice_NNS (_( +_NN 5_CD ±_NN 2_CD %_NN females_NNS vs_NNS ._. +_NN 12_CD ±_NN 2_CD %_NN males_NNS ,_, 
        P_NN <_NN 0_CD ._. 05_CD ,_, n_NN =_SYM 5_CD for_IN each_DT group_NN )_) ._.
        Saline_NNP injection_NN had_VBD no_DT effect_NN on_IN heart_NN rate_NN ._. After_IN 3_CD days_NNS
        of_IN repeated_VBN isoproterenol_NN injection_NN (_( 2_CD ._. 5_LS μg_NN /_NN g_SYM ,_, once_RB at_IN 9_CD AM_NNP
        and_CC once_RB at_IN 9_CD PM_NNP )_) ,_, heart_NN rate_NN in_IN males_NNS prior_RB to_TO the_DT 6_CD
        thinjection_NN was_VBD significantly_RB reduced_VBN compared_VBN to_TO control_VB
        heart_NN rate_NN in_IN males_NNS prior_RB to_TO the_DT 1_CD stinjection_NN ,_, whereas_IN the_DT
        heart_NN rate_NN in_IN females_NNS did_VBD not_RB change_VB ._. Both_DT male_JJ and_CC female_JJ
        mice_NNS exhibited_VBN significant_JJ acute_JJ increases_NNS in_IN heart_NN rate_NN
        (_( +_NN 27_CD ±_NN 6_CD %_NN males_NNS and_CC +_NN 22_CD ±_NN 3_CD %_NN females_NNS )_) after_IN the_DT 6_CD
        thinjection_NN of_IN the_DT drug_NN on_IN day_NN 3_CD (_( 
        P_NN <_NN 0_CD ._. 05_CD compared_VBN to_TO %_NN increases_NNS
        following_VBG 1_CD stinjection_NN on_IN day_NN 1_LS )_) ._. Fig_NNP ._. 3_LS illustrates_VBZ
        significant_JJ electrocardiographic_JJ alterations_NNS immediately_RB
        after_IN the_DT 1_CD stadministration_NN of_IN isoproterenol_NN on_IN day_NN 1_CD in_IN a_DT
        C_NNP 57_CD BL_NNP /_NN 6_CD male_JJ mouse_NN ._. ST_NNP segment_NN depression_NN ,_, suggestive_JJ of_IN
        acute_JJ subendocardial_NN ischemia_NN ,_, was_VBD consistently_RB observed_VBN in_IN
        C_NNP 57_CD BL_NNP /_NN 6_CD male_JJ mice_NNS but_CC not_RB in_IN all_DT female_JJ mice_NNS immediately_RB
        following_VBG administration_NN of_IN isoproterenol_NN ._. Heart_NNP weight_NN in_IN
        males_NNS and_CC females_NNS treated_VBN with_IN isoproterenol_NN for_IN 3_CD days_NNS was_VBD
        significantly_RB increased_VBN (_( 16_CD %_NN )_) compared_VBN to_TO hearts_NNS from_IN mice_NNS
        treated_VBN with_IN saline_NN for_IN 3_CD days_NNS (_( 
        P_NN <_NN 0_CD ._. 05_CD )_) ._.
      
      
        Discussion_NNP
        
          Strain_NNP &_CC Gender_NNP Differences_NNS in_IN ECGs_NNP in_IN Adult_NNP
          Mice_NNS
          To_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ study_NN to_TO describe_VB
          gender_NN differences_NNS in_IN heart_NN rate_NN in_IN genetically_RB
          homogenous_JJ strains_NNS of_IN conscious_JJ mice_NNS ._. Studies_NNS in_IN humans_NNS [_NN
          9_CD ,_, 10_CD ]_NN and_CC in_IN rats_NNS [_NN 11_CD ,_, 12_CD ]_NN have_VBP shown_VBN females_NNS to_TO have_VB
          faster_JJR heart_NN rates_NNS than_IN males_NNS ,_, differences_NNS that_WDT disappear_VBP
          with_IN age_NN [_NN 10_CD ,_, 13_CD ]_NN ._. In_IN C_NNP 57_CD BL_NNP /_NN 6_CD mice_NNS and_CC in_IN 129_CD /_NN Sv_NNP mice_NNS ,_,
          we_PRP found_VBD that_IN conscious_JJ females_NNS exhibited_VBN significantly_RB
          faster_JJR heart_NN rates_NNS than_IN male_JJ mice_NNS ._. In_IN FVB_NNP /_NN N_NNP mice_NNS ,_,
          however_RB ,_, we_PRP noted_VBD faster_JJR heart_NN rates_NNS and_CC briefer_NN ECG_NNP time_NN
          intervals_NNS in_IN male_JJ compared_VBN to_TO female_JJ mice_NNS ._. Mitchell_NNP et_CC
          al_NN ._. ,_, using_VBG implanted_VBN transmitters_NNS ,_, reported_VBD slightly_RB but_CC
          insignificantly_RB faster_JJR heart_NN rates_NNS in_IN male_JJ compared_VBN to_TO
          female_JJ FVB_NNP mice_NNS [_NN 4_CD ]_NN ._. Gender_NNP and_CC strain_NN differences_NNS in_IN
          heart_NN rate_NN may_MD reflect_VB differences_NNS in_IN hormone_NN activity_NN ,_,
          which_WDT are_VBP known_VBN to_TO affect_VB cardiovascular_JJ autonomic_JJ
          regulation_NN differentially_RB in_IN males_NNS and_CC females_NNS [_NN 9_CD ]_NN and_CC
          vary_VBP among_IN mouse_NN strains_NNS [_NN 14_CD ]_NN ._. Our_PRP$ strain-dependent_JJ
          observations_NNS agree_VBP with_IN results_NNS of_IN invasive_JJ studies_NNS [_NN 8_CD ,_,
          6_CD ]_NN and_CC support_VB the_DT importance_NN of_IN genetic_JJ factors_NNS in_IN
          influencing_VBG heart_NN rate_NN ._.
        
        
          Developmental_NNP Changes_NNS in_IN ECGs_NNP in_IN Conscious_NNP Neonatal_NNP
          Mice_NNS
          We_PRP found_VBD that_IN the_DT gender_NN differences_NNS apparent_JJ in_IN
          C_NNP 57_CD BL_NNP /_NN 6_CD adults_NNS were_VBD absent_JJ in_IN nursling_VBG mice_NNS ._. Reduced_NNP
          activity_NN in_IN newborns_NNS could_MD contribute_VB to_TO reduced_VBN heart_NN
          rate_NN and_CC heart_NN rate_NN variability_NN ._. However_RB ,_, observations_NNS in_IN
          quietly_RB resting_VBG adult_NN mice_NNS (_( n_NN =_SYM 3_LS )_) ,_, monitored_VBD 30_CD min_NN
          after_IN placement_NN on_IN the_DT recording_NN platform_NN ,_, of_IN reduced_VBN
          heart_NN rate_NN (_( 471_CD ±_NN 20_CD bpm_NN )_) and_CC increased_VBN heart_NN rate_NN
          variability_NN (_( 53_CD ±_NN 6_CD bpm_NN )_) suggest_VBP that_IN the_DT results_NNS in_IN
          neonates_NNS may_MD be_VB attributable_JJ to_TO reduced_VBN sympathetic_JJ and_CC
          parasympathetic_JJ signaling_VBG [_NN 15_CD ]_NN ._. The_DT time-domain_JJ heart_NN
          rate_NN variability_NN data_NNS we_PRP obtained_VBD non-invasively_JJ are_VBP
          comparable_JJ to_TO those_DT obtained_VBN using_VBG implanted_VBN telemetry_NN
          devices_NNS [_NN 2_CD ,_, 16_CD ]_NN ._. The_DT developmental_NN changes_NNS in_IN heart_NN rate_NN
          we_PRP measured_VBD in_IN mice_NNS parallel_VB those_DT in_IN human_JJ neonates_NNS [_NN
          13_CD ,_, 17_CD ]_NN ,_, lambs_NNS [_NN 18_CD ]_NN ,_, and_CC newborn_JJ rats_NNS [_NN 19_CD ]_NN ._. Moreover_RB ,_,
          our_PRP$ observations_NNS in_IN neonatal_NN mice_NNS are_VBP in_IN agreement_NN with_IN
          Wang_NNP et_CC al_NN ._. who_WP reported_VBD progressive_JJ and_CC significant_JJ
          shortening_NN of_IN R-R_NNP intervals_NNS during_IN neonatal_NN development_NN [_NN
          1_CD ]_NN ._. Accordingly_RB ,_, our_PRP$ approach_NN ,_, adaptable_JJ to_TO the_DT study_NN of_IN
          small_JJ mice_NNS that_WDT might_MD otherwise_RB die_VB from_IN anesthesia_NN or_CC
          surgery_NN ,_, might_MD be_VB valuable_JJ in_IN examining_VBG developmental_NN
          changes_NNS and_CC abnormalities_NNS [_NN 13_CD ,_, 17_CD ]_NN ._.
        
        
          Effects_NNPS of_IN Sympathetic_NNP Stimulation_NNP in_IN Conscious_NNP
          Mice_NNS
          The_DT blunted_VBN heart_NN rate_NN increase_NN in_IN response_NN to_TO
          β-adrenergic_JJ stimulation_NN in_IN conscious_JJ C_NNP 57_CD BL_NNP /_NN 6_CD female_JJ mice_NNS
          is_VBZ consistent_JJ with_IN gender_NN related_VBD differences_NNS in_IN
          baroreflex_NN control_NN of_IN heart_NN rate_NN in_IN healthy_JJ humans_NNS [_NN 20_CD ]_NN ._.
          Estrogen_NNP has_VBZ been_VBN shown_VBN to_TO enhance_VB baroreflex_NN sensitivity_NN
          [_NN 21_CD ]_NN and_CC attenuate_NN the_DT response_NN of_IN heart_NN rate_NN to_TO
          administration_NN of_IN isoproterenol_NN in_IN rats_NNS [_NN 22_CD ]_NN ._. After_IN
          repeated_VBN injections_NNS of_IN isoproterenol_NN ,_, heart_NN rate_NN
          decreased_VBD and_CC the_DT QRS_NNP duration_NN increased_VBN significantly_RB in_IN
          male_JJ mice_NNS ,_, but_CC did_VBD not_RB change_VB in_IN female_JJ mice_NNS ._. Yet_RB ,_, both_DT
          males_NNS and_CC females_NNS demonstrated_VBN increased_VBN sensitivity_NN to_TO
          acute_JJ isoproterenol_NN injection_NN after_IN repeated_VBN
          administration_NN that_WDT resulted_VBD in_IN significant_JJ cardiac_JJ
          hypertrophy_NN [_NN 23_CD ,_, 24_CD ]_NN ._. We_PRP observed_VBD a_DT 16_CD %_NN increase_NN in_IN
          heart_NN mass_NN in_IN both_DT sexes_NNS after_IN 3_CD -_: days_NNS of_IN isoproterenol_NN
          treatment_NN compared_VBN to_TO mice_NNS treated_VBN with_IN equivolume_NN of_IN
          saline_NN ._. Although_IN β-adrenoceptor_JJ desensitization_NN [_NN 23_CD ]_NN or_CC
          reduced_VBN ATPase_NNP activity_NN [_NN 25_CD ]_NN may_MD account_VB for_IN the_DT
          decrease_NN in_IN basal_NN heart_NN rate_NN in_IN the_DT hypertrophied_JJ male_JJ
          hearts_NNS ,_, the_DT increased_VBN sensitivity_NN to_TO isoproterenol_NN may_MD
          support_VB the_DT hypotheses_NNS of_IN ischemia-induced_JJ activation_NN of_IN
          β-adrenoceptor_JJ kinase_NN [_NN 26_CD ]_NN or_CC modulation_NN of_IN G-_NNP protein_NN
          signaling_VBG to_TO preserve_VB adenylate_NN cyclase_NN activity_NN [_NN 27_CD ]_NN ._.
          To_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN that_WDT describes_VBZ
          electrocardiographic_JJ evidence_NN of_IN myocardial_NN ischemia_NN in_IN
          conscious_JJ mice_NNS ,_, although_IN ST_NNP segment_NN changes_NNS have_VBP
          characterized_VBN isoproterenol-induced_JJ ischemia_NN in_IN rat_NN [_NN 28_CD ]_NN
          and_CC man_NN [_NN 29_CD ]_NN ._. Why_WRB males_NNS consistently_RB developed_VBN ST_NNP
          segment_NN depression_NN following_VBG isoproterenol_NN administration_NN
          and_CC females_NNS did_VBD not_RB remains_VBZ unanswered_JJ ._. However_RB ,_,
          significant_JJ gender-related_JJ differences_NNS in_IN the_DT expression_NN
          of_IN glutathione_NN S-_NNP transferases_NNS (_( GST_NNP )_) have_VBP been_VBN observed_VBN in_IN
          mice_NNS ,_, with_IN female_JJ mice_NNS expressing_VBG significantly_RB more_JJR of_IN
          this_DT antioxidant_NN than_IN male_JJ mice_NNS [_NN 30_CD ]_NN ._. In_IN mice_NNS ,_,
          isoproterenol-induced_JJ oxidative_JJ stress_NN may_MD be_VB attenuated_JJ
          in_IN females_NNS due_JJ to_TO higher_JJR levels_NNS of_IN GST_NNP [_NN 31_CD ]_NN ._.
        
        
          Study_NNP Limitations_NNPS
          Mice_NNS are_VBP sensitive_JJ to_TO even_RB modest_JJ handling_NN [_NN 3_CD ,_, 8_CD ]_NN and_CC
          transport_NN [_NN 3_CD ,_, 32_CD ]_NN ._. The_DT ECG_NNP indices_NNS we_PRP measured_VBD may_MD
          reflect_VB physiologic_JJ responses_NNS to_TO the_DT experimental_JJ
          environment_NN relative_JJ to_TO its_PRP$ home_NN cage_NN ._. We_PRP encourage_VBP a_DT 10_CD
          min_NN acclimation_NN period_NN prior_RB to_TO recording_NN data_NNS to_TO
          attenuate_NN effects_NNS consequent_JJ to_TO handling_VBG and_CC transport_NN ._.
          Usually_RB mice_NNS establish_VB contact_NN between_IN 3_CD electrodes_NNS and_CC 3_CD
          limbs_NNS within_IN 5_CD minutes_NNS after_IN acclimation_NN to_TO record_VB a_DT
          continuous_JJ ECG_NNP for_IN approximately_RB 2_CD seconds_NNS ._. The_DT duration_NN
          of_IN the_DT ECG_NNP recording_NN should_MD be_VB considered_VBN in_IN the_DT
          interpretation_NN of_IN heart_NN rate_NN variability_NN [_NN 33_CD ]_NN ._. The_DT age_NN ,_,
          gender_NN and_CC strain_NN variations_NNS in_IN heart_NN rate_NN may_MD reflect_VB
          age_NN ,_, gender_NN and_CC strain_NN variations_NNS in_IN physiologic_JJ
          responses_NNS to_TO transport_VB [_NN 32_CD ]_NN ,_, handling_VBG [_NN 3_CD ]_NN ,_, and_CC
          adaptation_NN to_TO repeated_VBN measurements_NNS [_NN 8_CD ]_NN ._. Yet_RB ,_, the_DT
          inter-strain_JJ differences_NNS in_IN heart_NN rate_NN we_PRP non-invasively_JJ
          obtained_VBN after_IN ECG_NNP recordings_NNS of_IN short_JJ duration_NN are_VBP in_IN
          agreement_NN with_IN invasive_JJ experimental_JJ techniques_NNS intended_VBN
          to_TO monitor_VB heart_NN rate_NN in_IN mice_NNS as_IN caged_JJ [_NN 6_CD ,_, 8_CD ]_NN ._. Our_PRP$
          measurements_NNS were_VBD made_VBN in_IN daytime_JJ hours_NNS ,_, disrupting_VBG the_DT
          less_RBR active_JJ phases_NNS of_IN the_DT mouse_NN circadian_NN cycle_NN ._. Future_JJ
          innovation_NN might_MD incorporate_VB an_DT array_NN of_IN conductive_JJ
          electrodes_NNS into_IN the_DT animals_NNS '_POS cages_NNS to_TO eliminate_VB the_DT
          effects_NNS of_IN handling_VBG and_CC transport_NN ,_, and_CC perhaps_RB enable_VB
          timed_VBN recordings_NNS ._.
        
      
      
        Materials_NNS and_CC Methods_NNP
        
          Mice_NNS
          Young_JJ adult_NN mice_NNS (_( 9_CD ±_NN 1_CD weeks_NNS old_JJ ;_: 21_CD ±_NN 1_CD g_SYM )_) from_IN 3_CD
          commonly_RB used_VBN inbred_JJ strains_NNS ,_, C_NNP 57_CD BL_NNP /_NN 6_CD ,_, 129_CD /_NN Sv_NNP ,_, and_CC FVB_NNP /_NN N_NNP
          (_( The_DT Jackson_NNP Laboratory_NNP ,_, Bar_NNP Harbor_NNP ,_, ME_NNP )_) ,_, were_VBD housed_VBN in_IN
          standard_JJ conditions_NNS within_IN the_DT Animal_NNP Resource_NNP Facility_NNP
          at_IN the_DT Beth_NNP Israel_NNP Deaconess_NNP Medical_NNP Center_NNP ,_, Boston_NNP MA_NNP ._.
          Nursling_NNP C_NNP 57_CD BL_NNP /_NN 6_CD mice_NNS of_IN either_DT sex_NN were_VBD examined_VBN at_IN
          post-natal_JJ day_NN 6_CD and_CC 12_CD and_CC returned_VBD to_TO their_PRP$ mothers_NNS ._.
          The_DT same_JJ mice_NNS ,_, weaned_JJ ,_, were_VBD examined_VBN at_IN 3_CD weeks_NNS of_IN
          age_NN ._.
        
        
          ECG_NNP recording_NN
          Mice_NNS were_VBD gently_RB removed_VBN from_IN their_PRP$ cages_NNS and_CC
          positioned_VBN on_IN the_DT ECG_NNP recording_NN platform_NN ._. An_DT array_NN of_IN
          gel-coated_JJ ECG_NNP electrodes_NNS (_( Red_NNP Dot_NNP ;_: 3_CD M_NNP ,_, St_NNP ._. Paul_NNP ,_, MN_NNP )_)
          were_VBD embedded_VBN in_IN the_DT floor_NN of_IN the_DT platform_NN and_CC spaced_JJ to_TO
          provide_VB contact_NN between_IN the_DT electrodes_NNS and_CC animals_NNS '_POS paws_NNS ._.
          For_IN adults_NNS ,_, the_DT spacing_VBG between_IN electrodes_NNS was_VBD 3_CD cm_NN ,_, and_CC
          for_IN nurslings_NNS ,_, the_DT spacing_VBG was_VBD reduced_VBN to_TO 2_CD ._. 5_CD cm_NN ._. Filter_NNP
          paper_NN ,_, with_IN openings_NNS for_IN the_DT electrodes_NNS ,_, prevented_VBN mouse_NN
          urine_NN from_IN short-circuiting_JJ the_DT signals_NNS ._. The_DT electrodes_NNS
          were_VBD connected_VBN to_TO an_DT amplifier_NN (_( HP_NNP 78901_CD A_DT ,_,
          Hewlett-_NNP Packard_NNP ,_, Andover_NNP ,_, MA_NNP )_) by_IN a_DT shielded_VBN 3_CD -_: electrode_NN
          lead_NN set_VBN (_( M_NNP 1605_CD A_DT Snap_NNP ,_, Hewlett-_NNP Packard_NNP ,_, Andover_NNP ,_, MA_NNP )_) ._.
          Since_IN even_RB modest_JJ handling_NN of_IN mice_NNS may_MD induce_VB alterations_NNS
          in_IN heart_NN rate_NN [_NN 6_CD ]_NN ,_, each_DT mouse_NN was_VBD permitted_VBN to_TO
          acclimatize_NN for_IN 10_CD min_NN prior_RB to_TO collection_NN of_IN baseline_NN
          data_NNS ._. The_DT signals_NNS were_VBD digitized_JJ with_IN 16_CD -_: bit_NN precision_NN
          (_( DI-_NNP 220_CD ,_, DATAQ_NNP Instruments_NNP ,_, Inc_NNP ._. ,_, Akron_NNP ,_, OH_NNP )_) at_IN a_DT
          sampling_VBG rate_NN of_IN 2500_CD samples_NNS /_NN second_JJ ._. When_WRB mice_NNS were_VBD
          sitting_VBG or_CC otherwise_RB positioned_VBN such_JJ that_IN the_DT paws_NNS were_VBD
          not_RB in_IN contact_NN with_IN three_CD electrodes_NNS ,_, the_DT output_NN from_IN the_DT
          amplifier_NN was_VBD discarded_VBN ._. Only_RB data_NNS from_IN continuous_JJ
          recordings_NNS of_IN 20_CD -_: 30_CD ECG_NNP signals_NNS were_VBD used_VBN in_IN the_DT
          analyses_NNS ._. Data_NNP were_VBD transmitted_VBN to_TO the_DT 
          mousespecifics_NNS ._. com_NN Internet_NN site_NN
          (_( Mouse_NNP Specifics_NNP ,_, Inc_NNP ._. ,_, Boston_NNP ,_, MA_NNP )_) using_VBG standard_JJ
          file-transfer_JJ protocols_NNS for_IN ECG_NNP signal_NN analyses_NNS by_IN
          e-_NN MOUSE_NNP ™_NN ._.
        
        
          ECG_NNP analyses_NNS
          Each_DT signal_NN was_VBD analyzed_VBN using_VBG e-_NN MOUSE_NNP ™_NN ,_, an_DT
          Internet-based_NNP physiologic_JJ waveform_NN analysis_NN portal_NN ._.
          e-_NN MOUSE_NNP ™_NN incorporates_VBZ Fourier_NNP analyses_NNS and_CC linear_JJ
          time-invariant_JJ digital_JJ filtering_VBG of_IN frequencies_NNS below_IN 2_CD
          Hz_NNP and_CC above_IN 100_CD Hz_NNP to_TO minimize_VB environmental_JJ signal_NN
          disturbances_NNS ._. The_DT software_NN uses_VBZ a_DT peak_NN detection_NN
          algorithm_NN to_TO find_VB the_DT peak_NN of_IN the_DT R-_NNP waves_NNS and_CC to_TO
          calculate_VB heart_NN rate_NN ._. Heart_NNP rate_NN variability_NN was_VBD
          calculated_VBN as_IN the_DT mean_NN of_IN the_DT differences_NNS between_IN
          sequential_NN heart_NN rates_NNS for_IN the_DT complete_JJ set_NN of_IN ECG_NNP
          signals_NNS ._. Subsequently_RB ,_, determination_NN of_IN 1_CD stand_VB 2_CD
          ndderivatives_NNS and_CC algebraic_JJ "_'' if-thens_JJ "_'' search_NN the_DT ECG_NNP
          signals_NNS for_IN probable_JJ P-_NNP wave_NN peaks_NNS and_CC onset_NN and_CC
          termination_NN of_IN QRS_NNP complexes_NNS ._. Since_IN the_DT T-_NNP wave_NN is_VBZ not_RB
          separate_JJ from_IN the_DT QRS_NNP in_IN rodent_NN ECGs_NNP [_NN 28_CD ,_, 34_CD ]_NN ,_, there_EX
          have_VBP been_VBN discrepancies_NNS in_IN the_DT definition_NN of_IN the_DT QT_NNP
          interval_NN and_CC reported_VBD values_NNS [_NN 4_CD ]_NN ._. In_IN accord_NN with_IN
          Mitchell_NNP et_CC al_NN ._. [_NN 4_CD ]_NN ,_, we_PRP routinely_RB included_VBD the_DT inverted_JJ
          and_CC /_NN or_CC biphasic_JJ portions_NNS of_IN the_DT T-_NNP wave_NN in_IN our_PRP$
          calculations_NNS of_IN the_DT QT_NNP interval_NN ._. We_PRP defined_VBD the_DT end_NN of_IN
          the_DT T-_NNP wave_NN of_IN each_DT signal_NN as_IN the_DT point_NN where_WRB the_DT signal_NN
          returned_VBD to_TO the_DT isoelectric_JJ line_NN [_NN 1_CD ,_, 35_CD ]_NN [_NN the_DT mean_JJ
          voltage_NN between_IN the_DT preceding_VBG P-_NNP wave_NN and_CC QRS_NNP interval_NN ]_NN ._.
          The_DT QT_NNP intervals_NNS were_VBD rate_NN corrected_VBN (_( QTc_NNP )_) by_IN application_NN
          of_IN the_DT equation_NN recommended_VBN by_IN Mitchell_NNP et_CC al_NN ._. [_NN 4_CD ]_NN for_IN
          use_NN in_IN mice_NNS ._. The_DT software_NN plots_NNS its_PRP$ interpretation_NN of_IN
          P_NN ,_, Q_NNP ,_, R_NN ,_, S_NNP ,_, and_CC T_NN for_IN each_DT beat_NN so_IN that_IN spurious_JJ data_NNS
          resulting_VBG from_IN unfiltered_JJ noise_NN or_CC motion_NN artifacts_NNS may_MD
          be_VB rejected_VBN ._. e-_NN MOUSE_NNP ™_NN then_RB calculates_VBZ the_DT mean_NN of_IN the_DT ECG_NNP
          time_NN intervals_NNS for_IN each_DT set_NN of_IN waveforms_NNS ._.
        
        
          β-adrenoceptor_JJ stimulation_NN
          To_TO test_VB the_DT sensitivity_NN of_IN our_PRP$ system_NN for_IN describing_VBG
          ECG_NNP alterations_NNS in_IN response_NN to_TO a_DT drug_NN ,_, C_NNP 57_CD BL_NNP /_NN 6_CD mice_NNS were_VBD
          given_VBN either_CC an_DT intraperitoneal_NN injection_NN of_IN 2_CD ._. 5_CD μg_NN /_NN g_SYM
          (_( -_: )_) -_: isoproterenol_NN (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) (_( 5_CD males_NNS ,_, 5_CD
          females_NNS )_) dissolved_VBN in_IN 0_CD ._. 1_CD ml_NN saline_NN or_CC an_DT equal_JJ volume_NN of_IN
          saline_NN (_( 5_CD males_NNS ,_, 5_CD females_NNS )_) ,_, twice_RB daily_JJ for_IN 3_CD -_: days_NNS ._. ECGs_NNP
          were_VBD recorded_VBN within_IN 5_CD min_NN prior_RB to_TO each_DT injection_NN and_CC
          between_IN 1_CD and_CC 2_CD min_NN after_IN each_DT injection_NN to_TO capture_VB the_DT
          peak_NN of_IN the_DT response_NN to_TO the_DT drug_NN [_NN 6_CD ]_NN ._. After_IN the_DT last_JJ
          measurement_NN ,_, mice_NNS were_VBD euthanized_JJ by_IN intraperitoneal_NN
          administration_NN of_IN pentobarbital_NN (_( 150_CD mg_NN /_NN Kg_NNP )_) ,_, consistent_JJ
          with_IN the_DT American_JJ Veterinary_JJ Medical_NNP Association_NNP Panel_NNP on_IN
          Euthanasia_NNP guidelines_NNS ._. Excised_NNP hearts_NNS ,_, excluding_VBG atria_NN
          and_CC blotted_JJ dry_JJ ,_, were_VBD then_RB weighed_VBN ._.
        
        
          Statistics_NNS
          Data_NNP are_VBP presented_VBN as_IN the_DT means_NNS ±_NN SE_NNP ._. Comparisons_NNP
          between_IN genders_NNS among_IN strains_NNS were_VBD performed_VBN using_VBG
          Student_NNP 's_POS 
          t_NN -_: test_NN for_IN unpaired_JJ observations_NNS ._.
          Effects_NNPS of_IN isoproterenol_NN or_CC saline_NN injections_NNS within_IN
          groups_NNS were_VBD performed_VBN using_VBG Student_NNP 's_POS 
          t_NN -_: test_NN for_IN paired_VBN observations_NNS ,_,
          and_CC between_IN group_NN comparisons_NNS using_VBG Student_NNP 's_POS 
          t_NN -_: test_NN for_IN unpaired_JJ observations_NNS ._.
          Differences_NNS were_VBD considered_VBN significant_JJ with_IN 
          P_NN <_NN 0_CD ._. 05_CD ._.
        
      
      
        Conclusions_NNP
        We_PRP developed_VBD a_DT non-invasive_JJ technique_NN for_IN obtaining_VBG ECGs_NNP
        in_IN conscious_JJ mice_NNS ._. We_PRP developed_VBD an_DT Internet-accessible_NNP
        portal_NN for_IN analyses_NNS of_IN mouse_NN electrocardiograms_NNS ._. Using_VBG this_DT
        system_NN ,_, we_PRP demonstrated_VBD significant_JJ strain_NN ,_, gender_NN and_CC
        age-dependent_JJ differences_NNS in_IN electrocardiograms_NNS in_IN mice_NNS ._.
        Moreover_RB ,_, we_PRP demonstrated_VBD significant_JJ gender-dependent_JJ
        differences_NNS in_IN the_DT cardiovascular_JJ response_NN to_TO
        β-adrenoceptor_JJ stimulation_NN ._. Our_PRP$ results_NNS may_MD suggest_VB that_IN
        the_DT stimulatory_NN effects_NNS of_IN genes_NNS and_CC drugs_NNS on_IN cardiac_JJ
        function_NN may_MD be_VB more_RBR profound_JJ in_IN male_JJ or_CC masked_VBN in_IN female_JJ
        mice_NNS ._. This_DT non-invasive_JJ and_CC rapid_JJ ECG_NNP phenotyping_VBG technique_NN
        may_MD improve_VB the_DT quality_NN and_CC increase_VB the_DT quantity_NN of_IN data_NNS
        collected_VBN from_IN mouse_NN models_NNS ._.
      
    
  
